β-Adrenoceptor density in patients with left-sided valvular regurgitation

Fundamental and Clinical Pharmacology

Volumn 10, Issue 6, 1996, Pages 547-553

  Dzimiri, N ^a   Moorji, A ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Mitral and aortic regurgitation; Rheumatic heart valvular disease; adrenoceptors

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR; DOPAMINE; NORADRENALIN;

ADULT; AORTA VALVE REGURGITATION; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; HUMAN; ISOTOPE LABELING; LYMPHOCYTE; MALE; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; RECEPTOR DENSITY;

EID: 0029848756     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1996.tb00613.x     Document Type: Article

References (23)

1. Anton AH, Sayre DF. A study of the factors affecting the aluminum oxide trihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 1962;138:360-75
2. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54
3. Bristow MR. Changes in myocardial and vascular receptors in heart failure. J Am Coll Cardiol 1993;22:61A-71A
4. Bristow MR, Ginsburg R, Miobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N Engl J Med 1982;307:205-11
5. Bristow MR, Kantrowitz NE, Ginsburg R, Fowler MB. β-Adrenergic function in heart muscle disease and heart failure. J Mol Cell Cardiol 1985;17(Suppl 2):41-52
6. Bristow MR, Hershberger RE, Port JD, Gilbert EM, Sandoval A, Rasmussen R, Cates AE, Feldman AM. β-Adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation 1990;82:I12-25
7. Brodde OE. Physiology and pharmacology of cardiovascular catecholamine receptors: implications for treatment of chronic heart failure. Am Heart J 1990;120:1565-72
8. Carabello BA. The changing unnatural history of valvular regurgitation. Ann Thorac Surg 1992;53:191-9
9. Conn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. New Engl J Med 1984;311:819-23
10. Daly PA, Sole MJ. Myocardial catecholamine and the pathophysiology of heart failure. Circulation 1990;82:I35-43
11. s-protein in patients with rheumatic heart valvular disease. Fundam Clin Pharmacol 1995a;9:372-80
12. Dzimiri N, Kumar M, Moorji A, Prabhakar G, Duran C. Effect of left ventricular pressure and volume overload on adrenoceptor activity in patients with left heart valve disease. J Am Coll Cardiol 1995b;(February, special issue):253 (abstr)
13. Dzimiri N, Moorji A, Kumar M, Kumar N, Halees Z. Comparison of the effect of left ventricular volume and pressure overload on β-adrenoceptor density in left heart valvular disease. Intern J Cardiol 1996;53:109-16
14. Hammond HK, Roth DA, Insel PA et al. Myocardial β-adrenergic receptor expression and signal transduction after chronic volume-overload hypertrophy and circulatory congestion. Circulation 1992;85:269-80
15. Homey CJ, Vatner SF, Vatner DE. β-Adrenergic receptor regulation in the heart in pathophysiological states: abnormal adrenergic responses in cardiac disease. Annu Rev Physiol 1991;53:137-59
16. Ledda F, Amerini S, Rubino L, Mantelli L. The role of the adrenergic system in the heart: regulation of contractility by cardiac adrenoceptors. Pharmacol Res 1991;24:3-19
17. Lefkowitz RJ, Inglese J, Koch WJ, Pitcher J, Attramadal H, Caron MG. G-protein-coupled receptors: regulatory role of receptor kinases and arrestin proteins. Cold Spring Harbor Symp Quant Biol 1992;LVII:127-33
18. Lohse MJ. Molecular mechanisms of membrane receptor desensitization. Biochim Biophys Acta 1993;1179:171-88
19. 2-adrenergic receptors. J Biol Chem 1993;268:3201-8
20. Prichard BNC, Owens CWI, Smith CCT, Walden RJ. Heart and catecholamines. Acta Cardiol 1991;XVLI:309-22
21. 2-adrenoceptors in the failing and nonfailing heart. Eur J Clin Pharmacol 1992;42:607-11
22. 2 adrenoceptor mRNA expression in normal and volume overloaded human. Cardiovasc Res 1991;25:737-41
23. 1-adrenergic receptor in the failing human heart. Circulation 1993; 87:454-63